Octreotide
Helps control excess hormone production, particularly growth hormone and certain gut hormones.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- octreotide acetate (somatostatin analog)
- Brand Names
- Sandostatin, Sandostatin LAR Depot
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Endocrine, Gastrointestinal
- Prescribing Specialties
- Endocrinology, Oncology, Gastroenterology
What it does
Octreotide is an FDA-approved medication that your doctor can prescribe. Synthetic somatostatin analog that inhibits growth hormone, glucagon, and insulin secretion, and reduces splanchnic blood flow and GI motility.
How it's taken
Subcutaneous injection (short-acting)
Monthly intramuscular injection (long-acting depot)
How people access it
Prescribed by specialists (endocrinology, oncology). Long-acting form administered monthly by a healthcare provider.
What doctors prescribe it for
- Acromegaly
- Severe diarrhea associated with carcinoid tumors
- Profuse watery diarrhea from VIPomas
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Octreotide through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for Sandostatin to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
Yes. Octreotide (Sandostatin, Sandostatin LAR Depot) is an FDA-approved drug product. It has undergone rigorous review of safety, efficacy, and manufacturing quality by the FDA. It can be legally prescribed by licensed clinicians for its approved indications.
Octreotide is FDA-approved for: Acromegaly; Severe diarrhea associated with carcinoid tumors; Profuse watery diarrhea from VIPomas. Off-label use may be considered by clinicians on a case-by-case basis, but only the labeled indications have been reviewed and approved by the FDA.
You can verify the approval status of Octreotide through several official FDA resources: DailyMed (dailymed.nlm.nih.gov) for current labeling, Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) for approval history, and the FDA Orange Book for therapeutic equivalence information. These are free, publicly available databases.
Want to learn more?
Explore how Octreotide compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides